SPOTLIGHT -
Slideshow
Author(s):
Once thought untreatable, we now have two FDA-approved medications for TD and a handful of off-label options. More in this research update.
Designing an Effective Treatment Strategy for Tardive Dyskinesia
Not All That Writhes Is Tardive Dyskinesia
How to Implement a Strategy for Treating Tardive Dyskinesia
Challenges in Treating Tardive Dyskinesia: How to Have Productive Conversations With Patients
Psychopharmacology Innovations
Deutetrabenazine Shows Long Term Efficacy and Safety in Patients with Tardive Dyskinesia